Expanded service offerings buoyed revenues for radiation therapy center operator US Oncology in the second quarter (end-June 30), while reduced U.S. reimbursement took its toll on profits.
Revenue totaled $753.4 million, down 9% compared with $689.4 million in the second quarter of 2006. The Houston-based company posted a net loss of $364,000, compared with net income of $8.6 million in year-ago quarter.
For the six-month period, revenue increased to $1.48 billion, up 6% from $1.39 billion in the same period of 2006. The company also reported a net loss of $15.9 million, compared with net income of $16.2 million in the first half of last year.
By AuntMinnie.com staff writers
August 14, 2007
Related Reading
US Oncology postpones Q2 results, August 8, 2007
US Oncology shows Q4 revenue uptick, February 22, 2007
Elekta inks US Oncology deal, August 31, 2006
US Oncology, Molecular Profiling Institute form cancer venture, August 4, 2006
US Oncology posts strong Q1, May 4, 2006
Copyright © 2007 AuntMinnie.com
